- Home
- CSBR vs RSF Comparison
CSBR vs RSF Comparison
Compare CSBR & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- RSF
- Stock Information
- Founded
- CSBR 1985
- RSF 2016
- Country
- CSBR United States
- RSF United States
- Employees
- CSBR N/A
- RSF N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- RSF Investment Managers
- Sector
- CSBR Health Care
- RSF Finance
- Exchange
- CSBR Nasdaq
- RSF Nasdaq
- Market Cap
- CSBR 60.6M
- RSF 52.0M
- IPO Year
- CSBR 1986
- RSF N/A
- Fundamental
- Price
- CSBR $5.23
- RSF $15.22
- Analyst Decision
- CSBR Strong Buy
- RSF
- Analyst Count
- CSBR 2
- RSF 0
- Target Price
- CSBR $6.75
- RSF N/A
- AVG Volume (30 Days)
- CSBR 129.1K
- RSF 11.8K
- Earning Date
- CSBR 09-11-2024
- RSF 01-01-0001
- Dividend Yield
- CSBR N/A
- RSF 10.61%
- EPS Growth
- CSBR N/A
- RSF N/A
- EPS
- CSBR N/A
- RSF N/A
- Revenue
- CSBR $51,655,000.00
- RSF N/A
- Revenue This Year
- CSBR $9.14
- RSF N/A
- Revenue Next Year
- CSBR $10.03
- RSF N/A
- P/E Ratio
- CSBR N/A
- RSF N/A
- Revenue Growth
- CSBR N/A
- RSF N/A
- 52 Week Low
- CSBR $3.60
- RSF $14.81
- 52 Week High
- CSBR $7.13
- RSF $16.23
- Technical
- Relative Strength Index (RSI)
- CSBR 67.10
- RSF 51.84
- Support Level
- CSBR $3.60
- RSF $15.27
- Resistance Level
- CSBR $5.23
- RSF $15.39
- Average True Range (ATR)
- CSBR 0.35
- RSF 0.08
- MACD
- CSBR 0.10
- RSF 0.02
- Stochastic Oscillator
- CSBR 87.57
- RSF 58.82
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.